
- Vol 38, Issue 1
- Volume 38
- Issue 01
New Beginnings, New Promises
As we close the door to the past, the promise of tomorrow is yet to come.
FROM THE CHAIRMAN
The beauty of a new year is the blank slate it presents. We close the book on the previous year, hopefully wiser from lessons learned, and charge forward expectantly. After last year, such a gift is particularly appreciated.
On that note, Psychiatric TimesTM is poised to jump into 2021 with great excitement. John J. Miller, MD, our editor in chief, explores the psychiatric treatments in the pipeline. Some of these agents leverage innovative psychopharmacology, and all offer the hope of improved outcomes for patients.
We also welcome new
This year we are excited to highlight contributions from our partner organizations and associations. In this issue, David “Daven” E. Morrison, MD, and colleagues from the Committee on Work & Organizations of the
There is much reason for optimism as we step into 2021: potential new treatments, a COVID-19 vaccine, and renewed hope and enthusiasm. Through it all, Psychiatric TimesTM is committed to keeping you up-to-date with the latest information and providing you with the resources you need to help your patients. If you have suggestions or requests to better assist you and your colleagues, let us know by emailing
Mike Hennessy Sr
Chairman and Founder, MJH Life SciencesTM
Articles in this issue
over 4 years ago
The Field as a Master Class in Interviewingover 4 years ago
The Promise and Potential of Emergency Psychiatryover 4 years ago
Improving Care in Teens With Opioid Use Disorderover 4 years ago
Benzodiazepine Use and the Risk of Dementiaalmost 5 years ago
My Patient Lost Their Job…Now What?almost 5 years ago
Two Hundred ThousandNewsletter
Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.